ProKidney Corp (NASDAQ:PROK) currently has a daily average trading volume of 12.68M but it saw 7399242 shares traded in last market. With a market cap of 1.03B USD, the company’s current market price of $3.52 came falling about -5.63 while comparing to the previous closing price of $3.73. In past 52 weeks, the stock remained buoying in the range of price level as high as $7.13 and as low as $0.46. In the recent trading on the day, stock has struck highest price mark of $3.52 while lowest mark touched by it was $4.05.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the BofA Securities which downgraded the stock as “Underperform” in its note to investors issued on June 30, 2025, recommending a price target of $1 for it. Guggenheim issued its recommendations for the stock as it initiated the price target for the stock is $6.
Over the week, PROK’s stock price is moving -32.05% down while it is 256.89% when we observe its performance for the past one month. Year-to-date it is 47.28% up and over the past year, the stock is showing an upside performance of 108.28%.
The company is expected to be releasing its next quarterly report on 2025-May-12, for which analysts forecasted an EPS of -0.15 while estimate for next year EPS is -0.56.
Currently, ProKidney Corp’s total number of outstanding shares is 129.54M with 30.05% of that held by the insiders while 41.66% of its common stock has been owned by the institutions. Stock’s beta reads 1.41. Stock has a price to sale or P/S ratio amounts to 3323.65. Its return on asset (ROA) is -17.24% on average.
